Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SYNERGY PHARMACEUTICALS, INC. | 6,513,342 | reported | 15 Jun 2018 | tx 36+7,847,714−1,746,596 |
| Hepion Pharmaceuticals, Inc. | 102,120 | reported | 19 Feb 2024 | tx 13+1,464,545 |
| Cardiff Oncology, Inc. | 76,106 | reported | 10 Jun 2021 | tx 28+448,455−25,954 |
| OKYO Pharma Ltd | 12,500 | reported | 19 May 2022 | tx 1+12,500 |
| Virpax Pharmaceuticals, Inc. | 12,091 | reported | 01 Jan 2022 | tx 3+28,774 |
| CALLISTO PHARMACEUTICALS INC | 0 | reported | 17 Jan 2013 | tx 12+782,500−2,037,245 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Feb 2024 | GRANT_AWARD | Hepion Pharmaceuticals, Inc. | 85,000 | 0.00 USD | deriv |
| 19 May 2022 | PURCHASE | OKYO Pharma Ltd | 12,500 | 4.00 USD | first after silence |
| 01 Jan 2022 | GRANT_AWARD | Virpax Pharmaceuticals, Inc. | 12,091 | 0.00 USD | deriv |
| 10 Jun 2021 | OTHER | Cardiff Oncology, Inc. | 755 | 0.00 USD | deriv |
| 10 Jun 2021 | OTHER | Cardiff Oncology, Inc. | 530 | 0.00 USD | deriv |
| 10 Jun 2021 | OTHER | Cardiff Oncology, Inc. | 223 | 0.00 USD | deriv |
| 10 Jun 2021 | OTHER | Cardiff Oncology, Inc. | 223 | 0.00 USD | deriv |
| 10 Jun 2021 | OTHER | Cardiff Oncology, Inc. | 218 | 0.00 USD | deriv |
| 10 Jun 2021 | OTHER | Cardiff Oncology, Inc. | 293 | 0.00 USD | deriv |
| 10 Jun 2021 | OTHER | Cardiff Oncology, Inc. | 44,734 | 0.00 USD | deriv |
| 10 Jun 2021 | OTHER | Cardiff Oncology, Inc. | 28,858 | 0.00 USD | deriv |
| 18 May 2021 | GRANT_AWARD | Hepion Pharmaceuticals, Inc. | 250,000 | 0.00 USD | deriv |
| 07 Apr 2021 | GRANT_AWARD | Virpax Pharmaceuticals, Inc. | 13,183 | 0.00 USD | deriv |
| 23 Mar 2021 | PURCHASE | Cardiff Oncology, Inc. | 470 | 10.40 USD | anomaly |
| 23 Mar 2021 | PURCHASE | Cardiff Oncology, Inc. | 1,900 | 10.42 USD | |
| 17 Feb 2021 | PURCHASE | Virpax Pharmaceuticals, Inc. | 3,500 | 6.79 USD | |
| 01 Dec 2020 | PURCHASE | Hepion Pharmaceuticals, Inc. | 12,000 | 1.66 USD | |
| 19 Aug 2020 | GRANT_AWARD | Hepion Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 17 Jun 2020 | GRANT_AWARD | Cardiff Oncology, Inc. | 28,858 | 0.00 USD | deriv |
| 14 May 2020 | PURCHASE | Cardiff Oncology, Inc. | 17,483 | 1.43 USD | first after silence |
| 03 Apr 2020 | GRANT_AWARD | Hepion Pharmaceuticals, Inc. | 60,000 | 0.00 USD | deriv |
| 24 Jul 2019 | GRANT_AWARD | Hepion Pharmaceuticals, Inc. | 970 | 0.00 USD | deriv |
| 20 Jun 2019 | GRANT_AWARD | Cardiff Oncology, Inc. | 44,734 | 0.00 USD | deriv |
| 03 Jul 2018 | PURCHASE | Hepion Pharmaceuticals, Inc. | 8,625 | 1000.00 USD | derivanomaly |
| 03 Jul 2018 | PURCHASE | Hepion Pharmaceuticals, Inc. | 15 | 1000.00 USD | derivfirst after silence |
6 purchases reported after at least 12 months of silence — most recent on 19 May 2022.